An artificial alanine-based amino acid (TioxAla), bearing a substituted triazolyl-thione group on the side chain and able to bind RNA biomedical targets, was here chosen as a valuable scaffold for the synthesis of new platinum complexes with potential dual action owing to the concomitant presence of the metal centre and the amino acid moiety. Three new platinum complexes, obtained from the reaction of TioxAla with K2PtCl4, were characterized by mass spectrometry, NMR and UV–vis spectroscopy: one compound (Pt1) consisted of two amino acid units coordinating the Pt(II) ion; the other two, Pt2 and Pt3, were isomers including in their structure one TioxAla unit, and two chlorides as Pt-ligands. Pt coordination involved preferentially the amino,...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
The discovery of cisplatin (cis-Pt(NH3)2Cl2) as an antineoplastic agent has focused attention on the...
An artificial alanine-based amino acid (TioxAla), bearing a substituted triazolyl-thione group on th...
An artificial alanine-based amino acid (S)-2-amino-3-[4-propyl-3-(thiophen-2-yl)-5-thioxo-4,5-dihydr...
An artificial alanine-based amino acid (S)-2-amino-3-[4-propyl-3-(thiophen-2-yl)-5-thioxo-4,5-dihydr...
An artificial alanine-based amino acid (S)-2-amino-3-[4-propyl-3-(thiophen-2-yl)-5-thioxo-4,5-dihydr...
We here report our studies on the reaction with the platinum(II) ion of a nucleoamino acid constitut...
We here report our studies on the reaction with the platinum(II) ion of a nucleoamino acid constitut...
Treatment of cis/trans-[PtCl2(N≡CR)2] 1 (R = CH3 (1a), C2H5 (1b), C6H5 (1c), CH2C6H4(p-CH3) (1d)) wi...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
[Formulae and special characters can only be approximated here. Please see the pdf version of the Ab...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
Abstract Three new series of homoleptic and heteroleptic platinum(II) β‐oxodithiocinnamic ester comp...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
The discovery of cisplatin (cis-Pt(NH3)2Cl2) as an antineoplastic agent has focused attention on the...
An artificial alanine-based amino acid (TioxAla), bearing a substituted triazolyl-thione group on th...
An artificial alanine-based amino acid (S)-2-amino-3-[4-propyl-3-(thiophen-2-yl)-5-thioxo-4,5-dihydr...
An artificial alanine-based amino acid (S)-2-amino-3-[4-propyl-3-(thiophen-2-yl)-5-thioxo-4,5-dihydr...
An artificial alanine-based amino acid (S)-2-amino-3-[4-propyl-3-(thiophen-2-yl)-5-thioxo-4,5-dihydr...
We here report our studies on the reaction with the platinum(II) ion of a nucleoamino acid constitut...
We here report our studies on the reaction with the platinum(II) ion of a nucleoamino acid constitut...
Treatment of cis/trans-[PtCl2(N≡CR)2] 1 (R = CH3 (1a), C2H5 (1b), C6H5 (1c), CH2C6H4(p-CH3) (1d)) wi...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
[Formulae and special characters can only be approximated here. Please see the pdf version of the Ab...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
Abstract Three new series of homoleptic and heteroleptic platinum(II) β‐oxodithiocinnamic ester comp...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
The use of Pt(IV) complexes as pro-drugs that are activated by intracellular reduction is a widely i...
The discovery of cisplatin (cis-Pt(NH3)2Cl2) as an antineoplastic agent has focused attention on the...